Legislation
- Title
- Health - Prescription Drug Affordability Board
- Sponsored by
- Delegates Pena-Melnyk, D. Barnes, Acevero, Anderson, Atterbeary, Bagnall, B. Barnes, Barron, Bartlett, Barve, Boyce, Bridges, Brooks, Cain, Cardin, Carey, Carr, Cassilly, Chang, Charkoudian, Charles, Ciliberti, Clippinger, Conaway, Corderman, Crosby, Crutchfield, D.M. Davis, D.E. Davis, Dumais, Ebersole, Feldmark, Fennell, W. Fisher, Fraser-Hidalgo, Gaines, Ghrist, Gilchrist, Glenn, Guyton, Harrison, Haynes, Healey, Hettleman, Hill, Holmes, Impallaria, Ivey, Jackson, Jalisi, Johnson, Jones, Kaiser, Kelly, Kerr, Korman, Krimm, Lafferty, Lehman, J. Lewis, R. Lewis, Lierman, Lisanti, Lopez, Love, Luedtke, McIntosh, Metzgar, Moon, Mosby, Palakovich Carr, Patterson, Proctor, Qi, Queen, Reilly, Reznik, Rogers, Rosenberg, Sample-Hughes, Shetty, Smith, Solomon, Stein, Stewart, Sydnor, Terrasa, Turner, Valderrama, Valentino-Smith, Walker, Washington, C. Watson, R. Watson, Wilkins, Wilson, K. Young, P. Young, Pendergrass, Bhandari, and Cullison
- Status
- Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 692
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Establishing the Prescription Drug Affordability Board to protect State residents and certain stakeholders from the high costs of prescription drug products; requiring the Board to collect data and identify prescription drug products that may cause affordability challenges; authorizing the Board to meet in closed session when discussing trade secrets; authorizing the Board to set an upper payment limit for certain drug products; creating a Stakeholder Council to assist the Board with certain reporting requirements; etc.
Committees
Details
Cross-filed with: SB0759
Bill File Type: Regular
Effective Date(s): July 1, 2019
Contingency - on a contingency described in Sec. 9 of the bill
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
21-2C-01 through 21-2C-15 )
Last Updated: 2/3/2020 2:31 PM